至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

Stem Cell Rev. 2016; 
ErbaniJohanna,AberdamDaniel,LargheroJerome,VanneauxValìCell Therapy Unit, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, F-75010, France.,University Paris Diderot, Sorbonne Paris Cité, Paris, F-75475, France. daniel.aberdam@inserm.fr.,Cell Therapy Unit, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, F-75010, France.,Cell Therapy Unit, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, F-75010, France. valerie.vanneaux@aphp
Products/Services Used Details Operation
Bacterial Expression System … hESMV preparations are screened to ensure absence of bacterial endotoxin in hESMVs using the GenScript ToxinSensor™ Chromogenic LAL Endotoxin Assay Kit, which utilizes a modified Limulus Amebocyte Lysate and a synthetic color producing substrate to quantitatively … Get A Quote

摘要

Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

关键词

Cornea,Exosomes,Limbal stem cell deficiency,Ocular surface diseases,Pluripotent stem cells,Secreted microvesi